Loading...

Ashwat Singh Dhillon, MD

TitleClinical Instructor of Medicine (Fellow)
InstitutionUniversity of Southern California
DepartmentMedicine
AddressHCT 1520 San Pablo St
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Cleveland Clinic - Fairview Hospital 2011  - 2012Best PGY2 Resident in Internal Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Dhillon’s research interests include management of coronary artery disease, valvular heart disease, peripheral vascular disease, hypertrophic cardiomyopathy and takotsubo cardiomyopathy.

    Dr. Dhillon earned his medical degree from Bharati Vidyapeeth University Medical College in India. He then completed residency training at Fairview Hospital in Cleveland, Ohio, a research fellowship in cardiac imaging at Cleveland Clinic, and a vascular medicine fellowship the Keck Medical Center of the University of Southern California, where he is currently a fellow in Cardiology and a Clinical Instructor in Medicine.


    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nairooz R, Saad M, Dhillon A, Yousaf H, Awar L, Mehra A, Matthews RV, Shavelle D, Clavijo L. Long term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2018 Jul 25. PMID: 30078629.
      View in: PubMed
    2. Dhillon A, Li S, Lewinger JP, Shavelle DM, Matthews RV, Clavijo LC, Weaver FA, Garg P. Comparison of devices used in carotid artery stenting: A vascular quality initiative analysis of commonly used carotid stents and embolic protection devices. Catheter Cardiovasc Interv. 2018 Jul 18. PMID: 30019819.
      View in: PubMed
    3. Desai MY, Smedira NG, Dhillon A, Masri A, Wazni O, Kanj M, Sato K, Thamilarasan M, Popovic ZB, Lever HM. Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria. J Thorac Cardiovasc Surg. 2018 Apr 12. PMID: 29735354.
      View in: PubMed
    4. Clavijo LC, Al-Asady N, Dhillon A, Matthews RV, Caro J, Tun H, Rowe V, Shavelle DM. Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia. Cardiovasc Revasc Med. 2017 Oct 28. PMID: 29221961.
      View in: PubMed
    5. Clavijo LC, Dhillon A, Al-Asady N, Matthews RV, Caro J, Tun H, Rowe V, Shavelle DM. Switch to Ticagrelor in critical limb ischemia antiplatelet study (STT-CLIPS). Cardiovasc Revasc Med. 2017 Sep 05. PMID: 29329963.
      View in: PubMed
    6. Dhillon A, Khanna A, Randhawa MS, Cywinski J, Saager L, Thamilarasan M, Lever HM, Desai MY. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery. Heart. 2016 10 15; 102(20):1627-32. PMID: 27288277.
      View in: PubMed
    7. Dhillon A, Desai M. Disease-modifying medical therapy in phenotypically overt hypertrophic cardiomyopathy: a case of too little, too late? Heart. 2016 02 15; 102(4):260-1. PMID: 26740485.
      View in: PubMed
    8. Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M, Agler D, Lytle BW, Lever HM, Desai MY. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. Circ Cardiovasc Imaging. 2015 Jul; 8(7):e003132. PMID: 26082555.
      View in: PubMed
    9. Dhillon A, Sweet W, Popovic ZB, Smedira NG, Thamilarasan M, Lytle BW, Tan C, Starling RC, Lever HM, Moravec CS, Desai MY. Association of noninvasively measured left ventricular mechanics with in vitro muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients. J Am Heart Assoc. 2014 Nov 11; 3(6):e001269. PMID: 25389286; PMCID: PMC4338715.
    10. Randhawa MS, Dhillon A, Taylor HC, Sun Z, Desai MY. Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. J Card Fail. 2014 May; 20(5):377.e25-31. PMID: 25089311.
      View in: PubMed
    11. Kobayashi T, Dhillon A, Popovic Z, Bhonsale A, Smedira NG, Thamilarasan M, Lytle BW, Lever HM, Desai MY. Differences in global and regional left ventricular myocardial mechanics in various morphologic subtypes of patients with obstructive hypertrophic cardiomyopathy referred for ventricular septal myotomy/myectomy. Am J Cardiol. 2014 Jun 01; 113(11):1879-85. PMID: 24837268.
      View in: PubMed
    12. Randhawa MS, Dhillon A, Desai MY. Incremental use of biomarkers and electrocardiogram in differentiating takotsubo cardiomyopathy from acute myocardial infarction: a potential way to go. J Card Fail. 2014 Apr; 20(4):292-3. PMID: 24480378.
      View in: PubMed
    13. Randhawa MS, Dhillon A, Taylor HC, Sun Z, Desai MY. Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. J Card Fail. 2014 Jan; 20(1):2-8. PMID: 24342256.
      View in: PubMed
    14. To AC, Dhillon A, Desai MY. Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2011 Oct; 4(10):1123-37. PMID: 21999873.
      View in: PubMed
    15. Desai MY, Dhillon A, To AC. Cardiac magnetic resonance in hypertrophic cardiomyopathy. Curr Cardiol Rep. 2011 Feb; 13(1):67-76. PMID: 20938759.
      View in: PubMed